• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. Alt-proteins: A promising future
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Chemical Profile of 4-chloro-2-ethylquinazoline (CAS No. 38154-40-4)

4-chloro-2-ethylquinazoline, identified by its Chemical Abstracts Service (CAS) number 38154-40-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinazoline class, a structural motif widely recognized for its biological activity and utility in drug development. The presence of both chloro and ethyl substituents on the quinazoline core imparts unique chemical properties that make it a valuable intermediate in synthetic chemistry and a potential candidate for further pharmacological exploration.

The molecular structure of 4-chloro-2-ethylquinazoline consists of a six-membered aromatic ring fused to a pyrimidine ring, with the chloro group attached at the 4-position and an ethyl group at the 2-position. This specific arrangement of substituents influences its reactivity, solubility, and interaction with biological targets. The chloro substituent, in particular, is known to enhance electrophilicity, making the molecule susceptible to nucleophilic substitution reactions, which are pivotal in medicinal chemistry for modifying and optimizing drug candidates.

In recent years, quinazoline derivatives have been extensively studied due to their diverse biological activities. Notably, compounds within this class have shown promise as kinase inhibitors, which are critical in treating various cancers and inflammatory diseases. The 4-chloro-2-ethylquinazoline scaffold provides a versatile platform for designing molecules that can modulate enzyme activity by binding to specific pockets on target proteins. This has led to several derivative compounds being investigated in preclinical studies for their potential therapeutic effects.

One of the most compelling aspects of 4-chloro-2-ethylquinazoline is its role as a key intermediate in the synthesis of more complex pharmacophores. Researchers have leveraged its structural features to develop novel molecules with enhanced efficacy and reduced side effects. For instance, modifications at the 3-position or 6-position of the quinazoline ring can introduce additional functional groups that improve metabolic stability or binding affinity. The chloro group at the 4-position also serves as a handle for further derivatization through cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, enabling the construction of biaryl structures that are prevalent in many active pharmaceutical ingredients (APIs).

Recent advancements in computational chemistry have further accelerated the discovery process for quinazoline derivatives like 4-chloro-2-ethylquinazoline. Molecular modeling techniques allow researchers to predict binding modes and interactions with biological targets with high accuracy, reducing the need for extensive experimental screening. This approach has been particularly valuable in identifying lead compounds for kinase inhibitors, where precise binding to ATP-binding pockets is essential. The ethyl substituent at the 2-position contributes to steric hindrance and can fine-tune interactions with protein targets, making it a crucial element in structure-based drug design.

The synthesis of 4-chloro-2-ethylquinazoline typically involves multi-step organic transformations starting from readily available precursors such as anthranilic acid or its derivatives. The introduction of the chloro group is often achieved through electrophilic aromatic substitution reactions, while the ethyl group can be incorporated via alkylation reactions. These synthetic routes highlight the compound's accessibility and utility as a building block in pharmaceutical research.

In addition to its applications in drug development, 4-chloro-2-ethylquinazoline has been explored for its potential use in materials science. Quinazoline derivatives exhibit interesting electronic properties due to their conjugated aromatic systems, making them candidates for organic semiconductors or luminescent materials. While this area of research is less developed compared to pharmaceutical applications, it represents an exciting frontier for future exploration.

The safety profile of 4-chloro-2-ethylquinazoline is another critical consideration in its handling and application. Although not classified as hazardous under standard conditions, appropriate laboratory practices should be followed when working with this compound. Good ventilation, personal protective equipment (PPE), such as gloves and safety goggles, are recommended to minimize exposure risks. Furthermore, storage conditions should be carefully controlled to prevent degradation or unintended reactions.

Future directions in research involving 4-chloro-2-ethylquinazoline may focus on expanding its biological activity profile through structural modifications. By integrating insights from genomics and proteomics data, researchers can identify new targets for quinazoline derivatives and design molecules with tailored properties. Additionally, green chemistry principles may guide synthetic approaches to make processes more sustainable and environmentally friendly.

In conclusion,4-chloro-2-ethylquinazoline (CAS No. 38154-40-4) is a multifaceted compound with significant potential in pharmaceuticals and materials science. Its unique structural features make it an attractive scaffold for drug discovery efforts aimed at developing kinase inhibitors and other therapeutic agents. As research continues to uncover new applications and synthetic methodologies,4-chloro-2-ethylquinazoline is poised to remain an important compound in both academic and industrial settings.

• 351426-07-8(Quinazoline,6-bromo-4-chloro-2-ethyl-)
• 38154-43-7(4,7-dichloro-2-methylquinazoline)
• 6484-24-8(4-chloro-2-methyl-quinazoline)
• 403612-89-5(2-tert-butyl-4-chloroquinazoline)
• 1245183-68-9(4,6-dichloro-2-cyclohexylquinazoline)
• 887590-80-9(Quinazoline,4,8-dichloro-2-(1-methylethyl)-)
• 887592-05-4(Quinazoline,4,8-dichloro-2-ethyl-)
• 38154-42-6(4-chloro-2-isopropylquinazoline)
• 258832-75-6(2-Quinazolineacetonitrile,4,6-dichloro-)
• 338739-44-9(4,6-Dichloro-2-methylquinazoline)